Abstract: Background: Agmatine, an endogenous amine, is cosidered a novel neuromodulator with neuroprotective properties. However, the mechanisms involved in these protective effects are poorly understood.
INTRODUCTION
Amgatine is an endogenous guanidine compound derived from decarboxylation of L-arginine. Given its several modulatory actions at the same time at multiple target sites, agmatine appears to be a potential therapeutic drug for different applications. Agmatine is considered to be a neurotransmitter and neuromodulator [1] and several studies have reported its therapeutic activity in neurological disorders [2] [3] [4] [5] [6] [7] [8] [9] . Of note, the treatment with agmatine showed protective effects against neurotoxic and ischemic injury in brain [1] as well as in a model of Parkinson's Disease (PD). Different mechanisms of action have been proposed to explain neuroprotective effects of agmatine, including NMDA receptor blokade [10, 11] and inhibition of nitric oxide synthase [12] [13] [14] , however, the exact mechanism is not well understood yet.
Recently, we have shown the capability of agmatine to protect neuronal-like SH-SY5Y cell line against rotenone damage, an in vitro model of PD. In particular, agmatine was able to inhibit the rotenone-induced activation of nuclear factor-κB (NF-κB), production of Reactive Oxygen Species (ROS), dissipation of mitochondrial membrane potential, and the activation of apoptotic pathways [15] . Furthermore, a close relationship between agmatine and improvement of mitochondrial function has been demonstrated [16, 17] .
Different experimental techniques are available to study biochemical and morphological alteration associated to pathological conditions. Fourier Transform Infrared (FTIR) spectroscopy is an extremely sensitive analytical technique that measures wavelength and intensity of the absorption of IR radiation and is used to identify changes at molecular level [18] [19] [20] . Several detailed information about the structure of isolated biomolecules are obtained by FTIR spectra; however an appropriate multivariate analysis allows to investigate also complex data from biological systems. Thus, it is possible to evaluate biochemical alterations associated with disease states, analyzing changes at the onset and during the progression of the disease.
This study was designed to evaluate by FTIR spectroscopy the protective effects of agmatine against molecular changes induced by rotenone exposure on differentiated SH-SY5Y cells, used as a model of PD.
MATERIALS AND METHODS
The human neuroblastoma cells SH-SY5Y (CRL-2266) were purchased from American Type Culture Collections (ATCC) (Rockville, Maryland, USA). Eagle's minimum essential medium, Ham's F-12 nutrient mixture, penicillin/streptomycin mixture, fetal bovine serum (FBS), all-trans retinoic acid (RA), 3-(4, 5-methylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT), 2',7'-dichlorofluorescein diacetate (H 2 DCF-DA), and other chemicals of analytical grade were purchased from Sigma (Milan, Italy).
CELL CULTURE AND TREATMENT
Neuroblastoma cells, SH-SY5Y, were cultured in MEM/Ham's F12 (1:1) medium supplemented with 10% FBS, 2 mM L-glutamine, 1 mM sodium pyruvate, and a solution of penicillin (10 U/ml) and streptomycin (100 mg/ml), and maintained at 37 °C in a humidified incubator with 5% CO 2 and 95% air. When the cells reached sub-confluent stage, SH-SY5Y were differentiated in complete culture medium with 1% FBS added of RA (10 M). After 5 days, differentiated cells were incubated for 24 h with 500 nM rotenone in the presence or absence of 250 nM of agmatine.
CELL VIABILITY AND ROS PRODUCTION
Cell viability was assessed by the colorimetric MTT assay as previously reported [15] .
To evaluate the production of intracellular ROS, at the end of rotenone treatment, cells were incubated with the probe 2'-7'-dichlorofluorescein diacetate (H 2 DCF-DA), as previously described [15] .
INFRARED SPECTROSCOPY
At the end of each treatment, SH-SY5Y cells were analyzed using FTIR spectroscopy. After rotenone incubation, differentiated cells were detached with a non enzymatic solution, re-suspended in PBS (50 l), transferred to a slide and air-dried. Then, the slides were put on CaF 2 windows and analyzed by FTIR spectroscopy using a Bruker Optics (Vertex 80 v spectrometer).
Mid-infrared (IR) spectra were collected in the range 4000-1200 cm -1 by means of 64 interferograms using a spectral resolution of 4 cm -1 . In addition, baseline-correction and area-normalization were used to treat and control samples, following the procedure described in Calabrò and Magazù [21, 22] . Finally, Fourier Self-Deconvolution (FSD) analysis was used to provide more qualitative information. Indeed FSD analysis allows to enhance vibration features and peak frequencies of IR spectra. Acquired spectra were analyzed by FSD using a band width Lorentzian shape of 16.3 and a deconvolution factor = 3.
STATISTICAL ANALYSIS
Each measurement was repeated using 12 samples treated as above described. For statistical evaluation, one-way ANOVA and the multiple comparison Tukey-Kramer test were used. P-values less than 0.05 were considered significant.
RESULTS
In this research, first we established rotenone effects on differentiated SH-SY5Y cells. As assessed by the MTT colorimetric assay, rotenone reduced cell viability up to 60±5.1% of control level. The pre-treatment with 250 nM of agmatine reduced the effects of rotenone on differentiated SH-SY5Y cells restoring cell viability up to 85±6% of controls (Fig. 1A) . Moreover, the exposure of cells to rotenone produced a significant increase in intracellular ROS production, while cell pre-incubation with agmatine reduced this effect (Fig. 1B) . Fig. (1) . Protective effects of agmatine against cell damage (A) and ROS production (B) induced by rotenone. Cell cultures were exposed for 24 h to 500 nM rotenone in absence or presence of 250 nM agmatine. A-Cell viability was assayed by MTT. Results are expressed as the mean ± SEM of at least five independent experiments. *p<0.05 significant differences versus control, § p<0.05 significant differences versus rotenone treatment. B-The production of ROS was assessed by DCF fluorescence. The results are expressed as as mean ± SEM of five independent experiments. *p<0.05 significant differences versus control, § p<0.05 significant differences versus rotenone. FTIR spectroscopy analysis was used to investigate rotenone damage in neuronal-like cells and to evaluate bioprotection of agmatine. First, after treatment with rotenone, an up-shift of Amide I band from 1,651 to 1,657 cm -1 and a significant decrease in intensity of Amide II mode at 1,538 cm -1 were observed (see Fig. 2 ). This result can be explained assuming that N-H bending and concomitant C-N stretching loss occurred after treatment with rotenone.
Furthermore, the bands around 1595-1560 cm -1 and 1430-1390 cm -1 increased in intensity after treatment with rotenone of neuronal-like cells. These vibrations can be assigned to asymmetric ( as COO-) and symmetric ( s COO-) stretching vibrations of unprotonated carboxyl group, respectively [23, 24] .
FTIR spectroscopy analysis was repeated using neuronallike SH-SY5Y cells exposed to rotenone with/without agmatine. It resulted that no significant changes occurred after the addition of agmatine (Fig. 2) .
The second step of FTIR spectroscopy analysis was represented by the use of FSD analysis to highlight the spectral structure of both control and treated cells. We observed the up-shift of Amide I in rotenone-treated cells (Fig. 3) . In addition, the incubation with rotenone caused an increase in the intensity of -sheet features (1,635 cm -1 and 1,685 cm -1 ) with respect to the -helix component. Nevertheless, no significant change of the -sheet structure was observed after the addition of agmatine (Fig. 3) .
In previous literature it was shown that in dying cells an increase by 20% of -sheet component in comparison to the -helix content in amide bands can be observed [25] . We know that transitions from -helix to -sheet vibrations produce aggregation processes that can be considered the first step to neurotoxicity, neurological disorders and some pathologies [26] [27] [28] .
Also, we observed a significant increase (p < 0.001) of the ratio between the integrated area of the as COO -stretching vibration band (computed from 1590 to 1570 cm -1 ) of rotenone treated and untreated samples, whereas no significant changes were found in cells pre-incubated with agmatine. However, the values of the integrated areas of asymmetric and symmetric stretching vibrations of carboxyl group in the presence or absence of rotenone and agmatine were reported in (Fig. 4) . Fig. (2) . Representative transmittance spectra in the amide I, II and III regions, of differentiated SH-SY5Y cells exposed to rotenone (dotted line), rotenone and agmatine (solid thin line) and unexposed (thick solid line). Fig. (3) . Fourier self-deconvolution analysis applied to the same spectra of Fig. (2) . Agmatine preincubation reduced the rotenone-induced increase of the -sheet contents at 1635 and 1685 cm -1 in the amide I region. In addition, it was highlighted the increase in intensity of symmetric and asymmetric stretching vibration of unprotonated carboxyl group around 1580 and 1420 cm 1 FSD analysis also evidenced the presence in IR spectra of CH 2 bending vibrations at 1,464 and 1,350 cm -1 . It was observed that the addition of rotenone induced these bands to downshift to 1,454 and 1,343 cm -1 , respectively (see Fig. 3 ). In addition, a significant increase of tyrosine vibration at 1,515 cm -1 occurred after the addition of rotenone in neuronal-like cells, as can be observed in Fig. (3) . In previous literature it was shown that the increase in intensity of tyrosine vibration can be considered a representative local marker for proteins, indicating the formation of hydrophobic cores in a protein [29] . Also this result suggests that proteins structure in neuronal-like cells changed after treatment with rotenone.
DISCUSSION
Agmatine, an endogenous amine derived from decarboxylation of arginine, is currently investigated for its neuroprotective properties. We have recently demonstrated the ability of agmatine to inhibit the toxicity of rotenone in neuroblastoma SH-SY5Y cells, a model of PD [15] . In the present research, we confirmed the oxidative stress induced by rotenone in neuronal-like differentiated SH-SY5Y cells, that was reduced by agmatine pretreatment. In addition, we assessed the link between modifications in the structures of protein and oxidative stress by using FTIR. This is a method widely used to examine for protein structural changes. FTIR analysis evidenced relevant alterations in the content of protein secondary structures occurred in the regions of amides I and II. In particular Amide I band appeared very strong in intensity and arises from the amide C=O stretching vibration and N-H bending mode [30] . In our experimental conditions, it resulted that the observed alterations in the amide I band due to the addition of rotenone are related to the alterations of the -sheet content in the region 1635-1620 cm -1 [31, 32] . In addition -turn content from 1,663 to 1,690 cm -1 was also increased as to thehelix component.
This alteration produced by the addition of rotenone in neuronal-like cells can be explained assuming the interaction of C=O and C-N groups of proteins with the polycation structure of rotenone. Otherwise, positive changes in the intensity of amide I and II bands, at 1,657 cm -1 and 1,545 cm -1 respectively, have been produced by the co-treatment with agmatine and rotenone, indicating higher cation-protein interaction associated with bioprotective effectiveness on protein secondary structures [33, 34] .
In rotenone-treated cells ATR spectra revealed an increase near 1,660 cm -1 of -turn content in comparison to the -helix component in the protein secondary structure. It has been reported that misfolded proteins, such as tubulin, are a common feature in PD [35] . Rotenone, in addition to inhibit the mitochondrial complex I, leads to microtubule dysfunction in vivo as well as in vitro [36, 37] and increase tubulin degradation. Toxin-dependent tubulin degradation is frequently associated with PD [38] . Furthermore, as a consequence of the inhibition of complex I, an overproduction of ROS occurs, leading to protein oxidation, as a result of their abundance in biological systems. As a result of ROS exposure, the most important changes that can occur in proteins include: amino acid modification, misfolding, fragmentation, aggregation, decrease or loss of biological function, or increase in proteolytic susceptibility [39] . The accumulation of toxic misfolded proteins may be a cell response to rotenone exposure [40] . Numerous complications in PD depend on altered protein folding triggered by oxidative stress conditions [41] . It is well known that agmatine exerts antioxidant properties acting as a free-radical scavenger, and here we showed its capacity to counteract rotenone-induced redox state alterations. Moreover, we demonstrated that antioxidant effects were associated to the reduction of -sheet structures [31, 32] . Many antioxidants may prevent the ROS-induced damage both directly reacting with ROS or free radical intermediates or indirectly modulating the activity of antioxidant and ROS-producing enzymes [42] . Scavenger effects of agmatine can be able to protect cells against apoptotic cell damage [15] . More studies should clarify if in addition to free-radical scavenging properties agmatine may also bind proteins and provide protection by a shielding mechanism. As demonstrated by FTIR detailed analysis, agmatine administration may counteract the alteration of protein folding induced by cell exposure to rotenone.
Further studies are required to characterize the mechanisms underlying agmatine protective effects. The antioxidant properties of natural compounds are of great interest and provide promising beneficial effects to support therapeutic strategy against neurodegenerative disorders.
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